Trastuzumab and Gefitinib in Treating Patients With Metastatic Breast Cancer

NCT00024154 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

132

Enrollment

NIH

Sponsor class

Conditions

Male Breast Cancer
Recurrent Breast Cancer
Stage IV Breast Cancer

Interventions

BIOLOGICAL: trastuzumab
DRUG: gefitinib
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)